Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
about
Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancerNew developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy.Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer.
P2860
Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hyaluronic acid-coated, prodru ...... ced pancreatic cancer therapy.
@en
type
label
Hyaluronic acid-coated, prodru ...... ced pancreatic cancer therapy.
@en
prefLabel
Hyaluronic acid-coated, prodru ...... ced pancreatic cancer therapy.
@en
P2093
P2860
P1476
Hyaluronic acid-coated, prodru ...... ced pancreatic cancer therapy.
@en
P2093
Jingrong Su
Yuzhu Zhan
Zhengrong Li
P2860
P304
P356
10.1080/03639045.2016.1226337
P407
P577
2016-08-24T00:00:00Z